Jo Yi-jin

Private Banker
· tracked since Jun 2026
Calls
4
Win Rate
75.0%
return
+3.2%
Calls 4 4 Posts tracked · 0.0/day
Calls
7d 0
30d 3
90d 3
Best Calls
128940.KS Long +13.9%
000660.KS Long +3.5%
COIN Long +1.6%
Worst Calls
035420.KS Long -6.1%
Most Mentioned
COIN ×1
000660.KS ×1
035420.KS ×1
Recent Calls
000660.KS Long 3 weeks ago
035420.KS Long 3 weeks ago
COIN Long 3 weeks ago
Win Rate 75% Long 4 Short 0
Win Rate
7d 75%
30d 0%
90d 100%
Average Return +3.2% Long Return +3.2% Short Return -
Average Return
7d +0.7%
30d -6.4%
90d +21.3%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 21
$1750000.00
+3.5%
Daily buybacks provide strong downside support.
SK Securities' daily buyback of 650,000 shares provides strong downside support for SK hynix, keeping the path open to 200,000 KRW.
AI Memory
Long
Aug 21
$220000.00
-6.1%
NAVER benefits from Dunamu merger and AI.
NAVER is an attractive domestic alternative due to its upcoming merger with Dunamu and its involvement in AI data centers.
Internet Platforms
Long
Aug 21
$172.35
+1.6%
High rates boost stablecoin issuers' reserve yields.
Stablecoin issuers like Circle and exchanges like Coinbase benefit from high interest rates by earning the spread on US Treasuries held as reserves.
Crypto Infrastructure
Long
Jun 11
$407500.00
+13.9%
Hanmi Pharm poised for catalyst-driven rebound.
Hanmi Pharm's stock has corrected to historical valuation lows while the company is poised for multiple near-term catalysts: a domestic obesity drug launch in Q4, a muscle-preserving obesity treatment in phase 3, a recent landmark $1.9 trillion KRW licensing deal with only a 6% up-front refundable payment, and potential further deals. The bio sector is deeply oversold and a single positive catalyst could reverse the entire selloff.
Pharma & Biotech
Showing 4 of 4 calls · sorted by mentions

Jo Yi-jin has 4 trade ideas tracked on Buzzberg across 4 tickers since June 2026. Most covered: COIN, 000660.KS, 035420.KS.